Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
   C01 CARDIAC THERAPY
   C02 ANTIHYPERTENSIVES
     C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING
     C02B ANTIADRENERGIC AGENTS, GANGLION-BLOCKING
     C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
     C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
     C02K OTHER ANTIHYPERTENSIVES
       C02KA Alkaloids, excl. rauwolfia
       C02KB Tyrosine hydroxylase inhibitors
       C02KC MAO inhibitors
       C02KD Serotonin antagonists
       C02KX Antihypertensive for pulmonary arterial hypertension
         C02KX01 Bosentan [DG:DG00266]
         C02KX02 Ambrisentan
         C02KX03 Sitaxentan [DG:DG00267]
         C02KX04 Macitentan
           D10135  Macitentan (JAN/USAN) <JP/US>
         C02KX05 Riociguat
         C02KX52 Ambrisentan and tadalafil
     C02L ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION
     C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02
   C03 DIURETICS
   C04 PERIPHERAL VASODILATORS
   C05 VASOPROTECTIVES
   C07 BETA BLOCKING AGENTS
   C08 CALCIUM CHANNEL BLOCKERS
   C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
   C10 LIPID MODIFYING AGENTS
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: February 22, 2019
According to WHO's ATC 2019

» Japanese version